While the influenza vaccine has endured its fair share of controversy, new research shed light on one of the flu shot’s added benefits: diabetes patients who get the vaccine may not suffer as many cardiovascular or respiratory problems.
Chlamydia is the most commonly reported sexually transmitted disease (STD) in the United States, according to the Centers for Disease Control and Prevention (CDC), and now the first steps toward creating a vaccine have been accomplished.
Researchers have described a novel strategy that could augment the current process for forecasting the naturally occurring mutations that help seasonal flu virus dodge the vaccine with a more precise approach.
Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.